Vivos (RDGL) EBITDA Margin (2010 - 2025)
Vivos (RDGL) posted EBITDA Margin of 4426.79% for Q4 2025, up 84.34% sequentially from 28260.94% in Q3 2025, and up 882246.0% YoY from N/an in Q4 2024.
Vivos (RDGL) EBITDA Margin (2010 - 2025) Analysis & Trends
Vivos has reported EBITDA Margin for 15 years, with the latest figure at 4426.79% in Q4 2025.
- Quarterly EBITDA Margin rose 882246.0% year-over-year to 4426.79% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 4628.68% (up 467435.0% YoY) and the FY2025 annual result came in at 4628.68%, up 467435.0% from the prior year.
- EBITDA Margin grew to 4426.79% in Q4 2025 per RDGL's latest filing, from 28260.94% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1307.07% in Q3 2021 and troughed at 28260.94% in Q3 2025.
- A 5-year average of 9058.02% and a median of 6625.15% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin surged 1019881 bps in 2024, then sank 1139804 bps in 2025.
- Over 5 years, EBITDA Margin stood at 1307.07% in 2021, then tumbled by 731 bps to 10857.87% in 2022, then increased by 10 bps to 9823.33% in 2023, then slumped by 35 bps to 13249.25% in 2024, then soared by 67 bps to 4426.79% in 2025.
- According to Business Quant data, EBITDA Margin over the past three periods registered 4426.79%, 28260.94%, and 4498.48% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | -4,426.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,426.79% |
| Sep 30, 2025 | -28,260.94% |
| Jun 30, 2025 | -4,498.48% |
| Mar 31, 2025 | -3,228.40% |
| Dec 31, 2024 | -13,249.25% |
| Sep 30, 2024 | -16,862.90% |
| Jun 30, 2024 | -3,868.96% |
| Mar 31, 2024 | -12,825.09% |
| Sep 30, 2023 | -9,823.33% |
| Jun 30, 2023 | -14,067.77% |
| Mar 31, 2023 | -4,138.63% |
| Dec 31, 2022 | -10,857.87% |
| Sep 30, 2022 | -4,262.54% |
| Jun 30, 2022 | -7,500.36% |
| Mar 31, 2022 | -5,749.95% |
| Sep 30, 2021 | -1,307.07% |
| Sep 30, 2020 | -1,834.86% |
| Dec 31, 2019 | -21,636.87% |
| Sep 30, 2019 | -7,590.09% |
| Mar 31, 2017 | -8,996.42% |